New valproate safety measures in the UK.
In: Reactions Weekly, Jg. 1995 (2024-02-17), Heft 1, S. 4-4
serialPeriodical
Zugriff:
The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented new safety measures for the use of valproate to reduce the risk of harm to babies if taken during pregnancy and the risk of impaired fertility in males. These measures include restrictions on starting valproate in new patients under 55 years old unless there are no other effective treatments or the reproductive risks do not apply. Women currently taking valproate should be reviewed at their next specialist visit and a second opinion is required for continued treatment. New educational materials have been introduced for healthcare professionals and patients, and it is advised to discuss these measures with healthcare professionals before making any changes to treatment. [Extracted from the article]
Titel: |
New valproate safety measures in the UK.
|
---|---|
Zeitschrift: | Reactions Weekly, Jg. 1995 (2024-02-17), Heft 1, S. 4-4 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 0114-9954 (print) |
DOI: | 10.1007/s40278-024-53267-7 |
Schlagwort: |
|
Sonstiges: |
|